Nonoguchi,
Legros,
Selvaggi,
Weggery,
Martens,
Murase,
Winkler,
Ellis,
Matsuura,
Serradeil-Le Gal,
Aceto,
Inoue,
Makino,
Murayama,
Suwa,
Breton,
Walker,
Otsuka,
Hendrick,
Leader,
Hanafusa,
Péqueux,
Iwasaki,
Morita,
McDonald,
Svelto,
Laera,
Ogura,
Pascal,
Miura,
Maffrand,
Wagnon,
Le Fur,
Garcia,
Hirakawa,
Pace,
Valenti,
Mune,
Morita,
Yasuda,
Daido,
Scott,
Günter Luckner,
Viktoria D. Mayr,
Stefan Jochberger,
Volker Wenzel,
Hanno Ulmer,
Walter R. Hasibeder,
Martin W. Dünser,
Hagelstein,
Mimura,
Oe,
Tobe,
Takeuchi,
Fukuda,
Yamakita,
Kishida,
Penza,
Bedford,
Tomita,
Geenen,
Gouraud,
Dinan,
Valette,
- Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Lolait, S.J., O'Carroll, A.M., McBride, O.W., Konig, M., Morel, A., Brownstein, M.J. Nature (1992)
- Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin. Willcutts, M.D., Felner, E., White, P.C. Hum. Mol. Genet. (1999)
- Close association of urinary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin-dependent antidiuresis in hyponatremia in elderly subjects. Ishikawa Se, n.u.l.l., Saito, T., Fukagawa, A., Higashiyama, M., Nakamura, T., Kusaka, I., Nagasaka, S., Honda, K., Saito, T. J. Clin. Endocrinol. Metab. (2001)
- Urinary excretion of aquaporin-2 water channel exaggerated dependent upon vasopressin in congestive heart failure. Funayama, H., Nakamura, T., Saito, T., Yoshimura, A., Saito, M., Kawakami, M., Ishikawa, S.E. Kidney Int. (2004)
- Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism. Kim, S.J., Young, L.J., Gonen, D., Veenstra-VanderWeele, J., Courchesne, R., Courchesne, E., Lord, C., Leventhal, B.L., Cook, E.H., Insel, T.R. Mol. Psychiatry (2002)
- Vasopressin as a target for antidepressant development: an assessment of the available evidence. Scott, L.V., Dinan, T.G. Journal of affective disorders. (2002)
- Do aquaporins have a role in nocturnal enuresis? Frøkiaer, J., Nielsen, S. Scandinavian journal of urology and nephrology. Supplementum. (1997)
- Plasma cortisol, PRL, ACTH, AVP and corticotrophin releasing hormone responses to direct current cardioversion and electroconvulsive therapy. Florkowski, C.M., Crozier, I.G., Nightingale, S., Evans, M.J., Ellis, M.J., Joyce, P., Donald, R.A. Clin. Endocrinol. (Oxf) (1996)
- Atrial natriuretic peptide in brain and pituitary gland. Gutkowska, J., Antunes-Rodrigues, J., McCann, S.M. Physiol. Rev. (1997)
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Abifadel, M., Varret, M., Rabès, J.P., Allard, D., Ouguerram, K., Devillers, M., Cruaud, C., Benjannet, S., Wickham, L., Erlich, D., Derré, A., Villéger, L., Farnier, M., Beucler, I., Bruckert, E., Chambaz, J., Chanu, B., Lecerf, J.M., Luc, G., Moulin, P., Weissenbach, J., Prat, A., Krempf, M., Junien, C., Seidah, N.G., Boileau, C. Nat. Genet. (2003)
- Letter: Problems with lithium as treatment for inappropriate ADH secretion. Handler, N., Uematsu, S., Long, D.M., Allen, G. N. Engl. J. Med. (1976)
- Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin. Geddes, B.J., Harding, T.C., Lightman, S.L., Uney, J.B. Nat. Med. (1997)
- Nephrogenic diabetes insipidus. Bichet, D.G. Am. J. Med. (1998)
- The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus. Inaba, S., Hatakeyama, H., Taniguchi, N., Miyamori, I. J. Clin. Endocrinol. Metab. (2001)
- Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Robben, J.H., Knoers, N.V., Deen, P.M. Am. J. Physiol. Renal Physiol. (2006)
- Synergistical effects of ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by pituitary adenoma of a patient with Nelson's syndrome in vitro. Chan, J.S., Gaspar, L., Iguchi, H., Seidah, N.G., Ling, N., Chrétien, M. Clinical and investigative medicine. Médecine clinique et experimentale. (1984)
- Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction. Donald, R.A., Crozier, I.G., Foy, S.G., Richards, A.M., Livesey, J.H., Ellis, M.J., Mattioli, L., Ikram, H. Clin. Endocrinol. (Oxf) (1994)
- Phosphorylation of the V2 vasopressin receptor. Innamorati, G., Sadeghi, H., Eberle, A.N., Birnbaumer, M. J. Biol. Chem. (1997)
- Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. Thibonnier, M., Auzan, C., Madhun, Z., Wilkins, P., Berti-Mattera, L., Clauser, E. J. Biol. Chem. (1994)
- Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function. Oksche, A., Schülein, R., Rutz, C., Liebenhoff, U., Dickson, J., Müller, H., Birnbaumer, M., Rosenthal, W. Mol. Pharmacol. (1996)
- Physiological effects of vasopressin and atrial natriuretic peptide in the collecting duct. Inoue, T., Nonoguchi, H., Tomita, K. Cardiovasc. Res. (2001)
- Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion. Kalogeras, K.T., Nieman, L.K., Friedman, T.C., Doppman, J.L., Cutler, G.B., Chrousos, G.P., Wilder, R.L., Gold, P.W., Yanovski, J.A. J. Clin. Invest. (1996)
- Identification of a novel A-kinase anchoring protein 18 isoform and evidence for its role in the vasopressin-induced aquaporin-2 shuttle in renal principal cells. Henn, V., Edemir, B., Stefan, E., Wiesner, B., Lorenz, D., Theilig, F., Schmitt, R., Vossebein, L., Tamma, G., Beyermann, M., Krause, E., Herberg, F.W., Valenti, G., Bachmann, S., Rosenthal, W., Klussmann, E. J. Biol. Chem. (2004)
- Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia. Mune, T., Murase, H., Yamakita, N., Fukuda, T., Murayama, M., Miura, A., Suwa, T., Hanafusa, J., Daido, H., Morita, H., Yasuda, K. J. Clin. Endocrinol. Metab. (2002)
- Galanin immunoreactive neurons in the human hypothalamus: colocalization with vasopressin-containing neurons. Gai, W.P., Geffen, L.B., Blessing, W.W. J. Comp. Neurol. (1990)
- Biochemical basis of partial nephrogenic diabetes insipidus phenotypes. Sadeghi, H., Robertson, G.L., Bichet, D.G., Innamorati, G., Birnbaumer, M. Mol. Endocrinol. (1997)
- Low-calcium diet in hypercalciuric enuretic children restores AQP2 excretion and improves clinical symptoms. Valenti, G., Laera, A., Gouraud, S., Pace, G., Aceto, G., Penza, R., Selvaggi, F.P., Svelto, M. Am. J. Physiol. Renal Physiol. (2002)
- Lithium-induced reduction in urinary concentrating ability and urinary aquaporin 2 (AQP2) excretion in healthy volunteers. Walker, R.J., Weggery, S., Bedford, J.J., McDonald, F.J., Ellis, G., Leader, J.P. Kidney Int. (2005)
- Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shock. Luckner, G., Mayr, V.D., Jochberger, S., Wenzel, V., Ulmer, H., Hasibeder, W.R., Dünser, M.W. Crit. Care Med. (2007)
- A single residue (arg46) located within the N-terminus of the V1a vasopressin receptor is critical for binding vasopressin but not peptide or nonpeptide antagonists. Hawtin, S.R., Wesley, V.J., Parslow, R.A., Simms, J., Miles, A., McEwan, K., Wheatley, M. Mol. Endocrinol. (2002)
- The effect of anti-diuretic hormone on the endolymphatic sac of the inner ear. Kumagami, H., Loewenheim, H., Beitz, E., Wild, K., Schwartz, H., Yamashita, K., Schultz, J., Paysan, J., Zenner, H.P., Ruppersberg, J.P. Pflugers Arch. (1998)
- Hypothalamic regulatory peptides and their receptors: cytochemical studies of their role in regulation at the adenohypophyseal level. Childs, G.V., Westlund, K.N., Tibolt, R.E., Lloyd, J.M. Journal of electron microscopy technique. (1991)
- Rapid corticosterone inhibition of corticotropin-releasing hormone binding and adrenocorticotropin release by enriched populations of corticotropes: counteractions by arginine vasopressin and its second messengers. Childs, G.V., Unabia, G. Endocrinology (1990)
- Galanin antagonizes vasopressin-stimulated flank marking in male golden hamsters. Ferris, C.F., Delville, Y., Bonigut, S., Miller, M.A. Brain Res. (1999)
- Structure-function correlates in the corticotropes of the anterior pituitary. Childs, G.V. Frontiers in neuroendocrinology. (1992)
- Neurotensin expressing neurons developed earlier than vasoactive intestinal polypeptide and vasopressin expressing neurons in the human suprachiasmatic nucleus. Xu, H., Hu, X.Y., Wu, L., Zhou, J.N. Neurosci. Lett. (2003)
- Ageing of the human hypothalamus. Swaab, D.F. Horm. Res. (1995)
- Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distention in humans. Miaskiewicz, S.L., Stricker, E.M., Verbalis, J.G. J. Clin. Endocrinol. Metab. (1989)
- Modulation of vasopressin-elicited water transport by trafficking of aquaporin2-containing vesicles. Ward, D.T., Hammond, T.G., Harris, H.W. Annu. Rev. Physiol. (1999)
- The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists. Thibonnier, M., Coles, P., Thibonnier, A., Shoham, M. Annu. Rev. Pharmacol. Toxicol. (2001)
- Regulation of pituitary ACTH secretion during chronic stress. Aguilera, G. Frontiers in neuroendocrinology. (1994)
- Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through autocrine/paracrine signaling. Péqueux, C., Breton, C., Hendrick, J.C., Hagelstein, M.T., Martens, H., Winkler, R., Geenen, V., Legros, J.J. Cancer Res. (2002)
- Urinary excretion of aquaporin-2 water channel protein in human and rat. Rai, T., Sekine, K., Kanno, K., Hata, K., Miura, M., Mizushima, A., Marumo, F., Sasaki, S. J. Am. Soc. Nephrol. (1997)
- Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus. Elias, L.L., Antunes-Rodrigues, J., Elias, P.C., Moreira, A.C. J. Clin. Endocrinol. Metab. (1997)
- Down-regulation of urinary AQP2 and unaffected response to hypertonic saline after 24 hours of fasting in humans. Starklint, J., Bech, J.N., Pedersen, E.B. Kidney Int. (2005)
- Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands. Serradeil-Le Gal, C., Wagnon, J., Valette, G., Garcia, G., Pascal, M., Maffrand, J.P., Le Fur, G. Prog. Brain Res. (2002)
- Relationship between adrenomedullin and vasopressin-aquaporin system under general anesthesia. Ogura, T., Morita, K., Takeuchi, M., Otsuka, F., Iwasaki, T., Oe, K., Matsuura, K., Tobe, K., Mimura, Y., Kishida, M., Makino, H., Hirakawa, M. Horm. Res. (2003)
- Molecular pharmacology and modeling of vasopressin receptors. Thibonnier, M., Coles, P., Thibonnier, A., Shoham, M. Prog. Brain Res. (2002)